- Subjects aged 13 years or older receiving renal transplants, who are newly
administered Rapamune after a contract is made between Pfizer Korea and an
investigator and/or an institution for conducting this study.
- Any patient who does not agree that Pfizer and companies working with Pfizer use
- Patients who have known hypersensitivity to Rapamune or its derivatives or any
excipients in the formulation.